Jennison Associates’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-515,643
| Closed | -$4.67M | – | 660 |
|
|
2019
Q3 | $4.67M | Buy |
+515,643
| New | +$4.67M | ﹤0.01% | 460 |
|
|
2015
Q3 | – | Sell |
-1,731,499
| Closed | -$19.2M | – | 748 |
|
|
2015
Q2 | $19.2M | Buy |
1,731,499
+13,577
| +0.8% | +$151K | 0.02% | 458 |
|
|
2015
Q1 | $26.9M | Buy |
1,717,922
+4,273
| +0.2% | +$67K | 0.02% | 408 |
|
|
2014
Q4 | $26.1M | Sell |
1,713,649
-54,743
| -3% | -$833K | 0.02% | 413 |
|
|
2014
Q3 | $19.1M | Sell |
1,768,392
-89,426
| -5% | -$964K | 0.02% | 438 |
|
|
2014
Q2 | $28.4M | Sell |
1,857,818
-158,395
| -8% | -$2.42M | 0.03% | 399 |
|
|
2014
Q1 | $36.5M | Buy |
2,016,213
+108,670
| +6% | +$1.96M | 0.03% | 375 |
|
|
2013
Q4 | $26.5M | Buy |
1,907,543
+421,045
| +28% | +$5.85M | 0.03% | 415 |
|
|
2013
Q3 | $15.6M | Buy |
+1,486,498
| New | +$15.6M | 0.02% | 453 |
|